FindTrial
Sign In

Assessment of quality of life and adherence to chemotherapy according to muscle mass and amount of exercise in patients receiving adjuvant chemotherapy after gastrectomy

Assessment of quality of life and adherence to chemotherapy according to muscle mass and amount of exercise in patients receiving adjuvant chemotherapy after gastrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007439
Enrollment
150
Registered
2022-06-23
Start date
2022-06-19
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients 19 years of age or older 2. Patients who are diagnosed with stage 2 or 3 gastric cancer after gastrectomy and are recommended for adjuvant chemotherapy

Exclusion criteria

Exclusion criteria: 1. Vulnerable subjects (pregnant, inability of communication) 2. Patients being treated for another cancer diagnosed within 5 years of the date of surgery 3. Patients determined to be ineligible for participation by the investigator

Design outcomes

Primary

MeasureTime frame
Quality of life assessed by EORTC QLQ C30, EORTC QLQ STO22, diet amount)—

Secondary

MeasureTime frame
Chemotherapy compliance—

Countries

Korea, Republic of

Contacts

Public ContactBang Wool Eom

National Cancer Center

kneeling79@ncc.re.kr+82-31-920-1689

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026